share_log

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

HC Wainwright & Co.维持对AngioDynamics的买入,将目标价上调至20美元
Benzinga ·  2023/10/05 07:12

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $19 to $20.

HC Wainwright&Co.分析师陈毅维持AngioDynamic(纳斯达克:ANGO)的买入,并将目标价从19美元上调至20美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发